Antimicrobial Resistance Diagnostics Global Market Report 2025

Description

Antimicrobial resistance (AMR) diagnostics are tests designed to detect microorganisms that have developed resistance to antibiotics or other antimicrobial agents. These diagnostics identify the specific pathogen and determine its resistance or susceptibility to various drugs, enabling targeted and effective treatment. AMR diagnostics play a crucial role in controlling the spread of resistant infections and guiding appropriate antimicrobial use in both clinical and public health settings.

The primary product types in the antimicrobial resistance diagnostics market include kits and reagents, instruments, and consumables. Kits and reagents consist of standardized chemicals and biological materials used to detect or measure specific pathogens or substances in diagnostic tests. These diagnostics target various pathogens such as drug-resistant Streptococcus pneumoniae (DRSP), drug-resistant Campylobacter (DRC), Clostridium difficile (CD), methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant Neisseria gonorrhoeae (DRNG), drug-resistant Salmonella (DRNTS), and other resistant organisms. A variety of technologies are employed, including microbiology culture, immunoassay, polymerase chain reaction (PCR), next-generation sequencing (NGS), mass spectrometry, rapid and point-of-care testing, and others. Key end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The antimicrobial resistance diagnostics market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance diagnostics market statistics, including the antimicrobial resistance diagnostics industry global market size, regional shares, competitors with the antimicrobial resistance diagnostics market share, detailed antimicrobial resistance diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the antimicrobial resistance diagnostics industry. This antimicrobial resistance diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antimicrobial resistance diagnostics market size has grown strongly in recent years. It will grow from $4.10 billion in 2024 to $4.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth observed during the historic period can be attributed to the increasing incidence of hospital-acquired infections, rising misuse of antibiotics in humans and animals, growing burden of multidrug-resistant organisms, expansion of public health surveillance programs, and increased diagnostic testing for infectious diseases.

The antimicrobial resistance diagnostics market size is expected to see strong growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth during the forecast period can be attributed to the growing demand for rapid diagnostic tools, increasing awareness of antimicrobial stewardship, rising government funding for resistance tracking, expanding use of point-of-care testing, and an increasing need for early infection detection. Major trends expected in this period include technological advancements in diagnostic platforms, innovations in resistance gene detection methods, increased investment in research and development, development of portable testing devices, and advancements in multiplex and high-throughput testing.

The increasing prevalence of drug-resistant infections is expected to drive the growth of the antimicrobial resistance diagnostics market moving forward. Drug-resistant infections occur when bacteria, viruses, fungi, or parasites develop mechanisms that allow them to survive treatments that were once effective, making standard therapies less effective and infections more difficult to manage. The rise in drug-resistant infections is largely due to the overuse of antibiotics in agriculture, where low-dose antimicrobials are regularly added to animal feed, encouraging resistance that can be transmitted to humans through the food supply. Antimicrobial resistance diagnostics, including rapid genetic assays and culture-based sensitivity tests, are crucial in addressing this issue by enabling early detection of resistant pathogens, guiding targeted treatments, and minimizing the inappropriate use of broad-spectrum antibiotics. For example, in November 2023, a report by the UK Health Security Agency (UKHSA) noted that antibiotic-resistant infections in England increased from 55,792 cases in 2021 to about 58,224 in 2022, representing a 4% rise in antimicrobial resistance nationwide. Hence, the growing prevalence of drug-resistant infections is fueling the antimicrobial resistance diagnostics market.

Leading companies in the antimicrobial resistance diagnostics market are developing advanced products such as multiplex polymerase chain reaction (PCR) assays that detect multiple pathogens and resistance genes simultaneously to improve diagnostic speed and accuracy. Multiplex PCR uses multiple primer sets in one reaction to identify different DNA targets concurrently, significantly saving time and resources. For instance, in May 2022, Vela Diagnostics, a molecular diagnostics company based in Singapore, introduced the PathoKey MP urinary tract infections (UTI) ID and antimicrobial resistance (AMR) PCR Test. This test allows for the simultaneous detection of 14 urinary tract infection pathogens and 14 antimicrobial resistance genes, supports both automated and manual workflows, and delivers results in as little as four hours to facilitate rapid, lab-scale AMR profiling. The PathoKey MP UTI ID & AMR PCR Test is designed to equip clinical laboratories with faster, high-throughput detection tools to support early intervention and effective antibiotic treatment.

In May 2022, bioMerieux S.A., a biotechnology company headquartered in France, acquired the remaining shares of Specific Diagnostics, LLC for $380 million (€360 million). This acquisition strengthens bioMerieux's dedication to advancing rapid antimicrobial susceptibility testing by incorporating Specific Diagnostics' patented REVEAL Rapid antimicrobial susceptibility testing (AST) system. The REVEAL system provides phenotypic AST results directly from positive blood cultures in an average of five hours. Specific Diagnostics, LLC, based in the United States, specializes in rapid, metabolomic signature-based antimicrobial susceptibility testing platforms designed for phenotypic analysis directly from blood culture samples.

Major players in the antimicrobial resistance diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Seegene Inc., Alifax S.r.l., Accelerate Diagnostics Inc., Lumos Diagnostics Holdings Pty Ltd, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc., OpGen Inc., T2 Biosystems, Jiangsu Medomics Medical Technology Co. Ltd.

North America was the largest region in the antimicrobial resistance diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antimicrobial resistance diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antimicrobial resistance diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial resistance diagnostics market consists of revenues earned by entities by providing services such as pathogen identification, resistance gene detection, rapid screening, antimicrobial susceptibility testing, and diagnostic data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance diagnostics market includes sales of polymerase chain reaction (PCR) instruments, immunoassay kits, point-of-care testing devices, sequencing reagents, and microbiology culture consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antimicrobial Resistance Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antimicrobial resistance diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial resistance diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Kits And Reagents; Instruments And Consumables
2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP); Drug Resistant Campylobacter (DRC); Clostridium Difficile (CD); Methicillin Resistant Staphylococcus Aureus (MRSA); Drug Resistant Neisseria Gonorrhoeae (DRNG); Drug Resistant Salmonella (DRntS); Other Pathogens
3) By Technology: Microbiology Culture; Immunoassay; PCR (Polymerase Chain Reaction); NGS (Next-Generation Sequencing); Mass Spectrometry; Rapid And Point Of Care; Other Technologies
4) By End-User: Hospitals And Clinics; Diagnostics Laboratories; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Polymerase Chain Reaction (PCR) Reagents; Immunoassay Reagents; Stains And Dyes; Culture Media
2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines; Ultraviolet-Visible (UV-Vis) Spectrophotometers; Next-Generation Sequencing (NGS) Systems; Microarray Scanners; Automated Liquid Handlers; Sample Collection Tubes And Swabs
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; bioMerieux S.A.; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Seegene Inc.; Alifax S.r.l.; Accelerate Diagnostics Inc.; Lumos Diagnostics Holdings Pty Ltd; Molsid SAS; Genetic Signatures Limited; iFAST Diagnostics Ltd; Astek Diagnostics Inc.; OpGen Inc.; T2 Biosystems; Jiangsu Medomics Medical Technology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r36925

1. Executive Summary

2. Antimicrobial Resistance Diagnostics Market Characteristics

3. Antimicrobial Resistance Diagnostics Market Trends And Strategies

4. Antimicrobial Resistance Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Antimicrobial Resistance Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Antimicrobial Resistance Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antimicrobial Resistance Diagnostics Market Growth Rate Analysis
5.4. Global Antimicrobial Resistance Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antimicrobial Resistance Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antimicrobial Resistance Diagnostics Total Addressable Market (TAM)

6. Antimicrobial Resistance Diagnostics Market Segmentation

6.1. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kits And Reagents
Instruments And Consumables
6.2. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Resistant Streptococcus Pneumoniae (DRSP)
Drug Resistant Campylobacter (DRC)
Clostridium Difficile (CD)
Methicillin Resistant Staphylococcus Aureus (MRSA)
Drug Resistant Neisseria Gonorrhoeae (DRNG)
Drug Resistant Salmonella (DRntS)
Other Pathogens
6.3. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microbiology Culture
Immunoassay
PCR (Polymerase Chain Reaction)
NGS (Next-Generation Sequencing)
Mass Spectrometry
Rapid And Point Of Care
Other Technologies
6.4. Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostics Laboratories
Research Institutes
Pharmaceutical And Biotechnology Companies
Other End Users
6.5. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid (DNA) Extraction Kits
Ribonucleic Acid (RNA) Extraction Kits
Polymerase Chain Reaction (PCR) Reagents
Immunoassay Reagents
Stains And Dyes
Culture Media
6.6. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Machines
Ultraviolet-Visible (UV-Vis) Spectrophotometers
Next-Generation Sequencing (NGS) Systems
Microarray Scanners
Automated Liquid Handlers
Sample Collection Tubes And Swabs

7. Antimicrobial Resistance Diagnostics Market Regional And Country Analysis

7.1. Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antimicrobial Resistance Diagnostics Market

8.1. Asia-Pacific Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antimicrobial Resistance Diagnostics Market

9.1. China Antimicrobial Resistance Diagnostics Market Overview
9.2. China Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antimicrobial Resistance Diagnostics Market

10.1. India Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antimicrobial Resistance Diagnostics Market

11.1. Japan Antimicrobial Resistance Diagnostics Market Overview
11.2. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antimicrobial Resistance Diagnostics Market

12.1. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antimicrobial Resistance Diagnostics Market

13.1. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antimicrobial Resistance Diagnostics Market

14.1. South Korea Antimicrobial Resistance Diagnostics Market Overview
14.2. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antimicrobial Resistance Diagnostics Market

15.1. Western Europe Antimicrobial Resistance Diagnostics Market Overview
15.2. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antimicrobial Resistance Diagnostics Market

16.1. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antimicrobial Resistance Diagnostics Market

17.1. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antimicrobial Resistance Diagnostics Market

18.1. France Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antimicrobial Resistance Diagnostics Market

19.1. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antimicrobial Resistance Diagnostics Market

20.1. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antimicrobial Resistance Diagnostics Market

21.1. Eastern Europe Antimicrobial Resistance Diagnostics Market Overview
21.2. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antimicrobial Resistance Diagnostics Market

22.1. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antimicrobial Resistance Diagnostics Market

23.1. North America Antimicrobial Resistance Diagnostics Market Overview
23.2. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antimicrobial Resistance Diagnostics Market

24.1. USA Antimicrobial Resistance Diagnostics Market Overview
24.2. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antimicrobial Resistance Diagnostics Market

25.1. Canada Antimicrobial Resistance Diagnostics Market Overview
25.2. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antimicrobial Resistance Diagnostics Market

26.1. South America Antimicrobial Resistance Diagnostics Market Overview
26.2. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antimicrobial Resistance Diagnostics Market

27.1. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antimicrobial Resistance Diagnostics Market

28.1. Middle East Antimicrobial Resistance Diagnostics Market Overview
28.2. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antimicrobial Resistance Diagnostics Market

29.1. Africa Antimicrobial Resistance Diagnostics Market Overview
29.2. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antimicrobial Resistance Diagnostics Market Competitive Landscape And Company Profiles

30.1. Antimicrobial Resistance Diagnostics Market Competitive Landscape
30.2. Antimicrobial Resistance Diagnostics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Antimicrobial Resistance Diagnostics Market Other Major And Innovative Companies

31.1. bioMerieux S.A.
31.2. Sysmex Corporation
31.3. Bio-Rad Laboratories Inc.
31.4. QIAGEN N.V.
31.5. Seegene Inc.
31.6. Alifax S.r.l.
31.7. Accelerate Diagnostics Inc.
31.8. Lumos Diagnostics Holdings Pty Ltd
31.9. Molsid SAS
31.10. Genetic Signatures Limited
31.11. iFAST Diagnostics Ltd
31.12. Astek Diagnostics Inc.
31.13. OpGen Inc.
31.14. T2 Biosystems
31.15. Jiangsu Medomics Medical Technology Co. Ltd.

32. Global Antimicrobial Resistance Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Resistance Diagnostics Market

34. Recent Developments In The Antimicrobial Resistance Diagnostics Market

35. Antimicrobial Resistance Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Antimicrobial Resistance Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Antimicrobial Resistance Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Antimicrobial Resistance Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer